Portal de investigação
Multidimensional phenotyping of severe asthma patients and its impact on disease control and therapeutic response - analysis from the Portuguese Severe Asthma Registry.
Dados básicos
- Código:
- Estudo Clínico Observacional (RAG-SPP-GSK)
- Protocolo:
- Estudo Clínico Observacional (RAG-SPP-GSK)
- EUDRACT:
- NCT:
- Centro:
- Dotação:
- Ano de início:
- 2022
- Ano de conclusão:
Objectivos do projeto
Tipo de Estudo: Estudo Observacional – Iniciativa da Indústria; Subtipo: Outro; Fase: Outro; Natureza do Promotor: Indústria Farmacêutica– Tipo comercial; Tipo de Centro: Unicêntrico - Doença investigada: Asma – Participantes recrutados: 100
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
A systematic review on experimental studies about patient adherence to treatment
Folkvord, F; (...); Lupi??ez Villanueva, F
Article. 10.1002/prp2.1166. 2024
Adherence to inhaled corticosteroids and long-acting ?2-agonists in asthma: A MASK-air study
Sousa Pinto, B.; (...); Bousquet, J
Article. 10.1016/j.pulmoe.2023.07.004. 2023
Aerobiology of Olive Pollen (Olea europaea L.) in the Atmosphere of the Iberian Peninsula
Penedos, Claudia; (...); Ferreira, Manuel Branco
Article. 10.3390/atmos15091087. 2024
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
Scelo, Ghislaine; (...); Porsbjerg, Celeste
Article. 10.1016/j.anai.2023.08.021. 2024
Artificial Intelligence-Supported Development of Health Guideline Questions.
Sousa-Pinto B; (...); Schünemann HJ
Article. 10.7326/ANNALS-24-00363. 2024
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma.
Porsbjerg CM; (...); Price DB
Article. 10.3389/fimmu.2024.1361891. 2024
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
Wechsler, Michael E.; (...); Price, David B.
Article. 10.1164/rccm.202305-0808OC. 2024
Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study
Sousa-Pinto, Bernardo; (...); MASK-Air Think Tank
Article. 10.1111/pai.14080. 2024
Asthma hospitalizations: A call for a national strategy to fight health inequities
Vieira, RJ; (...); Fonseca, J
Editorial Material. 10.1016/j.pulmoe.2022.12.001. 2023
Clinical remission following biologic initiation in severe asthma: results of the International Severe Asthma Registry (ISAR)
Scelo, G; (...); Price, D
Meeting Abstract. 10.1183/13993003.congress-2023.PA1891. 2023
Co-creation of a self-learning programme for patients with asthma: patients' and health professionals' perspectives on the relevant topics
Jácome, C; (...); Sá-Sousa, A
Meeting Abstract. 10.1183/13993003.congress-2023.PA488. 2023
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, PE; (...); Price, DB
Article. 10.1111/all.15711. 2023
Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air(®).
Bousquet J; (...); Zuberbier T
Article. 10.1002/clt2.12390. 2024
ConectAR - collaborative network of patients with chronic respiratory diseases and carers actively involved in health research: An initiative for the patient and public involvement
Sá-Sousa, A; (...); Jácome, C
Meeting Abstract. 2023
Content validity of a patient-reported experience measure (CQRA-PREM) for patients with rheumatoid arthritis in Portugal
Rainho, R; (...); Jácome, C
Article. 2023
Content validity of a patient-reported experience measure (CQRA-PREM) for patients with rheumatoid arthritis in Portugal.
Rainho R; (...); Jácome C
Article. 2023
Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma.
Sousa-Pinto B, Fonseca JA, Bousquet J
Article. 10.18176/jiaci.0994. 2024
C-reactive protein-to-albumin ratio and six-month mortality in incident hemodialysis patients.
Sant'Ana M; (...); Lopes JA
Article. 10.1080/0886022X.2023.2182615. 2023
Cross-cultural validation of the Short-Form Vascular Access Questionnaire
Barros, JP; (...); Cruz-Correia, R
Article. 10.1177/11297298231170407. 2023
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Sousa Pinto, B.; (...); Bousquet, J
Article. 10.1016/j.jaip.2022.12.005. 2023
Characteristics associated with clinical remission in patients with severe asthma who initiate biologics
De Llano, LP; (...); Price, D
Meeting Abstract. 10.1183/13993003.congress-2023.PA1892. 2023
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
Sousa Pinto, B.; (...); Bousquet, J
Article. 10.1016/S2589-7500(23)00020-1. 2023
Development and validation of novel individualized FeNO cut-offs
Amaral, R; (...); Alving, K
Meeting Abstract. 10.1183/13993003.congress-2023.PA4499. 2023
Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach
Bousquet, J; (...); Zuberbier, T
Article. 10.1002/clt2.12215. 2023
Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper
Pfaar, Oliver; (...); Bousquet, Jean
Article. 10.1111/all.16135. 2024
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta-analysis.
Sousa-Pinto B; (...); Bousquet J
Article. 10.1111/all.16384. 2025
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma.
Scelo G; (...); Price DB
Article. 10.1016/j.jaip.2024.05.016. 2024
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.
Perez-de-Llano L; (...); Price DB
Article. 10.1164/rccm.202311-2192OC. 2024
From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).
Sousa-Pinto B; (...); Bousquet J
Article. 10.18176/jiaci.0923. 2024
Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries-The @IT.2020 multicenter study.
Dramburg S; (...); Matricardi PM
Article. 10.1111/all.16029. 2024
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Bousquet, J; (...); Fonseca, JA
Article. 10.1016/j.pulmoe.2022.10.005. 2023
Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real-World Data MASK-air Study.
Vieira RJ; (...); Sousa-Pinto B
Article. 10.1016/j.jaip.2024.07.026. 2024
Impact of Allergic Rhinitis on Academic Performance in Adolescents and Adults: a Bayesian Analysis of MASK-air® Real-world Direct Patient Data.
Vieira RJ; (...); Sousa-Pinto B
Article. 10.18176/jiaci.1010. 2024
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
Chen, WJ; (...); Price, DB
Article. 10.1016/j.jaip.2023.05.044. 2023
Impact of multimorbidity patterns in hospital admissions: the case study of asthma
Portela, D; (...); Pinto, BS
Article. 10.1080/02770903.2023.2185154. 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
Perez-de-Llano L; (...); Price DB
Article. 10.1016/j.anai.2023.12.023. 2024
Impact of the COVID-19 Pandemic on the Prescribing of Antiasthmatic Treatments in Portugal: A Nationwide Study
Silva, TM; (...); Gomes, ER
Article. 10.1016/j.clinthera.2023.01.003. 2023
Impact of Uncontrolled Symptoms on the Health-Related Quality of Life (EQ-5D-5L) of Patients With Allergic Rhinitis: A MASK-air Study
Vieira, Rafael Jose; (...); Sousa-Pinto, Bernardo
Article. 10.1111/cea.14516. 2024
Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study
Sousa-Pinto, B; (...); Bousquet, J
Article. 10.1016/j.jaip.2023.08.006. 2023
Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study
Bousquet, J; (...); Pfaar, O
Letter. 10.1111/cea.14318. 2023
Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis.
Sousa-Pinto B; (...); Bousquet J
Article. 10.1016/j.jaci.2024.04.016. 2024
Intranasal antihistamines and corticosteroids in the treatment of allergic rhinitis: a systematic review and meta-analysis protocol
Sousa Pinto, B.; (...); Bousquet, J
Review. 10.1136/bmjopen-2023-076614. 2023
Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis.
Torres MI; (...); Vieira RJ
Article. 10.1016/j.jaip.2024.09.001. 2024
MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases.
Bousquet J; (...); Zuberbier T
Article. 10.1016/j.jaip.2024.03.024. 2024
MASK-air® real-world data in respiratory allergy in old-age adults
Taborda-Barata, L; (...); Sousa Pinto, B.
Letter. 10.1002/clt2.12216. 2023
MASK-air® direct patient data support the ARIA-MeDALL hypothesis on allergic phenotypes
Bousquet, J; (...); ARIA Grp
Letter. 10.1111/all.15842. 2023
Measurement properties of the Portuguese version of the rheumatoid arthritis patient-reported experience measure (CQRA-PREM): a cross-sectional single center study.
Oliveira D; (...); Jácome C
Article. 2024
Measuring adherence to inhaled control medication in patients with asthma: Comparison among an asthma app, patient self-report and physician assessment
Cachim, A; (...); Jacome, C
Article. 10.1002/clt2.12210. 2023
Multidisciplinary Development and Initial Validation of a Clinical Knowledge Base on Chronic Respiratory Diseases for mHealth Decision Support Systems
Pereira, A.; (...); Fonseca, JA
Article. 10.2196/45364. 2023
PAAI - Interactive online self-learning programme for patients with asthma: A patient- and carer-centred approach on the most relevant topics to address
Jácome, C; (...); Sá-Sousa, A
Meeting Abstract. 2023
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report
Bousquet, J; (...); Ollert, M
Review. 10.1111/all.15740. 2023
Patients' Satisfaction with Remote Asthma Medical Follow-Up Before and During the COVID-19 Pandemic
Alexandre, L; (...); Jacome, C
Article. 10.1089/tmj.2022.0370. 2023
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study.
Vieira RJ; (...); Sousa-Pinto B
Article. 10.1016/j.jaip.2024.03.036. 2024
Protocol for the systematic reviews on the desirable and undesirable effects of pharmacological treatments of allergic rhinitis informing the ARIA 2024 guidelines.
Vieira RJ; (...); Sousa-Pinto B
Article. 10.5414/ALX02515E. 2024
Public involvement in chronic respiratory diseases research: A qualitative study of patients', carers' and citizens' perspectives
Areia, Margarida; (...); Jacome, Cristina
Article. 10.1111/hex.13917. 2024
Real world biologic treatment response in severe asthma: an analysis of the International Severe Asthma Registry (ISAR)
Le, TT; (...); Price, D
Meeting Abstract. 10.1183/13993003.congress-2023.PA1894. 2023
Real-world associations between outcomes and biomarkers in severe asthma patients treated with biologics
Townend, J; (...); Price, D
Meeting Abstract. 10.1183/13993003.congress-2023.PA1897. 2023
Real-world biologics response and super-response in the International Severe Asthma Registry cohort
Denton, Eve; (...); Price, David B.
Article. 10.1111/all.16178. 2024
Regional, sex, and age inequities in asthma hospital admissions in Spain and Portugal
Vieira, Rafael Jose; (...); Sousa-Pinto, Bernardo
Letter. 10.1002/clt2.12349. 2024
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study
Sousa-Pinto, Bernardo; (...); MASK Air Think Tank
Article. 10.1002/clt2.12358. 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
Chen W; (...); Price DB
Letter. 10.1016/j.jaip.2023.12.008. 2024
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
Bousquet, J; (...); Anto, JM
Review. 10.1111/all.15679. 2023
Self-reported adverse reactions to subcutaneous airborne allergen immunotherapy: a real-life, single center study
Pereira, AM; (...); Fonseca, JA
Article. 10.23822/EurAnnACI.1764-1489.212. 2023
Software as a Medical Device (SaMD) in Digestive Healthcare: Regulatory Challenges and Ethical Implications
Mascarenhas, Miguel; (...); Macedo, Guilherme
Review. 10.3390/diagnostics14182100. 2024
Symptoms of anxiety and depression in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies
Cunha, MS; (...); Jacome, C
Article. 10.1136/bmjopen-2022-068725. 2023
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paper
Smolinska, S; (...); Chivato, T
Article. 10.1111/all.15964. 2023
Ten year citation prediction model for systematic reviews using early years citation data
Marques-Cruz, Manuel; (...); Sousa-Pinto, Bernardo
Article. 10.1007/s11192-024-05105-0. 2024
UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan
Bousquet, J; (...); Zuberbier, T
Review. 10.1111/all.15855. 2023
Understanding beliefs about inhaled medication in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies.
Novais C; (...); Jácome C
Article. 10.23822/EurAnnACI.1764-1489.344. 2024
Unsupervised algorithms to identify potential under-coding of secondary diagnoses in hospitalisations databases in Portugal
Portela, D; (...); Sousa Pinto, B.
Article. 10.1177/18333583221144663. 2023
Validation of the adult asthma epidemiological score: a secondary analysis of the EPI-ASTHMA population-based study.
Laranjeira C; (...); Fonseca JA
Article. 10.1136/bmjopen-2024-086493. 2024
Weight associates positively with FeNO in adult females but not males in a large healthy populationbased sample
Jacinto, T; (...); Alving, K
Meeting Abstract. 10.1183/13993003.congress-2023.OA758. 2023
